Effect of Shengeyifei Capsule on Inflammatory Mediators in Rat with Chronic Obstructive Pulmonary Disearse
Mao Cai-ping
Abstract
Mao Cai-ping
Abstract
Objective To observe the effect of Shengeyifei capsule on the inflammatory mediators in the airway and the pathology of the airway in the rat with chronic obstructive pulmonary diserse (COPD). Methods 60 SD rats were divided randomly into normal group, COPD model group, Jinshuibao control group and Shengeyifei groups. The COPD model was established by smoking and infusing lipopoly- saccharide (LPS). The level of interleukin-8 (IL-8) and tumor necrosis factor α (TNF-α) in bronchoalveolar lavage fluid (BALF) were measured and the pathology of the airway and lung tissue was observed after treatment on the rats. Result The levels of IL-8 and TNF-α in Shengeyifei groups were lower than in COPD model group (P 0.01), the pathological changes were also lessen in Shengeyifei groups. Conclusion Shengeyifei capsule has inhibitory effect on inflammation in the airway with COPD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of Shengeyifei capsule on the inflammatory mediators in the airway and the pathology of the airway in the rat with chronic obstructive pulmonary diserse (COPD). Methods 60 SD rats were divided randomly into normal group, COPD model group, Jinshuibao control group and Shengeyifei groups. The COPD model was established by smoking and infusing lipopoly- saccharide (LPS). The level of interleukin-8 (IL-8) and tumor necrosis factor α (TNF-α) in bronchoalveolar lavage fluid (BALF) were measured and the pathology of the airway and lung tissue was observed after treatment on the rats. Result The levels of IL-8 and TNF-α in Shengeyifei groups were lower than in COPD model group (P 0.01), the pathological changes were also lessen in Shengeyifei groups. Conclusion Shengeyifei capsule has inhibitory effect on inflammation in the airway with COPD.
Key concepts: COPD, Medicine, Bronchoalveolar lavage, Capsule, Tumor necrosis factor alpha, Airway, Pathological, Inflammation